Coronavirus (COVID-19) Update: FDA Authorizes Pharmacists to Prescribe Paxlovid with Certain Limitations
U.S. Food and Drug Administration revised the Emergency Use Authorization (EUA) for Paxlovid (nirmatrelvir and ritonavir), to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients, with certain limitations to ensure appropriate patient assessment and prescribing of Paxlovid. Source
Why Not Everyone Should Take Paxlovid
Paxlovid is not meant for everyone. Only those who are at increased risk for severe disease from COVID-19 qualify for the drug, including people over age 12 who have weakened immune systems or other health conditions that increase risk of serious effects of COVID-19—like asthma, cancer, liver disease, lung disease, heart disease, and obesity. Click here to read full article
Other Health Updates
- CDC warns of <em>Salmonella</em> Infections linked to Contaminated Basil sold at Trader Joe’sCDC warns of Salmonella infections linked to contaminated basil sold at Trader Joe’s
- CDC’s Disease Detectives Share Findings from the Forefront of Public HealthThe CDC will hold its annual Epidemic Intelligence Service (EIS) Conference from April 23–26, 2024, in Atlanta, GA. The EIS Conference is the nation’s flagship applied epidemiology conference where EIS officers share their work on leading-edge investigations, scientific findings, and forward-thinking strategies to inform improvements in public health.
- New U.S Global Health Security Strategy Advances Commitment to Protect Americans and People Around the World from Emerging Health ThreatsAdvancing the Administration’s commitment to protect the American people from the next pandemic, the White House today released The United States Government Global Health Security Strategy (GHSS) 2024, which acknowledges that the United States and the international community can only achieve global, sustainable health security by working with all countries.
- CDC Investigating Harmful Reactions to Counterfeit Botox
- CDC Data Modernization Efforts Accelerate Nation’s Ability to Detect and Rapidly Respond to Health ThreatsToday the Centers for Disease Control and Prevention (CDC) launched its updated Public Health Data Strategy for 2024-2025 and a companion 2023 Lookback Report.
- CDC Data Modernization Efforts Accelerate Nation’s Ability to Detect and Rapidly Respond to Health ThreatsToday the Centers for Disease Control and Prevention (CDC) launched its updated Public Health Data Strategy for 2024-2025 and a companion 2023 Lookback Report.
- Transcript for Vital Signs: Health-Related Social Needs Can Keep Women from Getting Lifesaving MammogramsTranscript for Vital Signs: Health-Related Social Needs Can Keep Women from Getting Lifesaving Mammograms
- Cost and Access Are Not the Only Barriers Women Face in Getting Lifesaving MammogramsA new CDC Vital Signs study finds that only about 65% of women ages 50-74, with three or more health-related social needs, are up to date with their mammograms. Breast cancer causes more than 40,000 deaths in women each year in the United States, and screening mammograms have been shown to reduce breast cancer deaths.
- Highly Pathogenic Avian Influenza A (H5N1) Virus Infection Reported in a Person in the U.S.April 1, 2024—A person in the United States has tested positive for highly pathogenic avian influenza (HPAI) A(H5N1) virus (“H5N1 bird flu”), as reported by Texas and confirmed by CDC.
- CDC’s National Institute for Occupational Safety and Health’s Impact Wellbeing™ Campaign Releases Hospital-Tested Guide to Improve Healthcare Worker BurnoutAs part of the first federal campaign to address healthcare worker burnout, the Centers for Disease Control and Prevention’s (CDC) National Institute for Occupational Safety and Health (NIOSH) today released an evidence-informed and actionable guide for the nation’s hospital leaders to improve healthcare worker wellbeing – Impact Wellbeing™ Guide: Taking Action to Improve Healthcare Worker […]